Clinical Trial Update: Oxygen Therapy During Acute Respiratory Failure in Immuno-compromised Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update on oxygen therapy using a high-flow cannula in immunocompromised patients with acute respiratory failure; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Failure

Drugs mentioned

• High Flow Oxygen Cannula

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Acute Respiratory Failure, Immunocompromised Host | Phase 3 | Status: COMPLETED